+499.5%
MRNA vs EQNR
+85.2%
+414.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EQNR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -2.5% |
| 7D | +5.5% | +1.7% | +3.8% | +5.9% |
| 30D | +158.7% | +11.5% | +147.3% | +166.1% |
| 3M | +182.1% | +12.9% | +169.2% | +194.3% |
| 6M | +151.8% | +36.0% | +115.9% | +161.3% |
| YTD | +393.6% | +84.1% | +309.4% | +415.9% |
| 1Y | +499.5% | +83.8% | +415.7% | +530.7% |
| All | +499.5% | +85.2% | +414.2% | +530.7% |
Cumulative growth
Daily Returns
Daily percentage return beside EQNR.
Daily Out/Under-Performance
Portfolio return minus EQNR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQNR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EQNR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling